Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health, Inc.    GH

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Guardant Health: 3Q Earnings Snapshot

11/05/2020 | 04:15pm EST

REDWOOD CITY, Calif. (AP) _ Guardant Health Inc. (GH) on Thursday reported a loss of $77.7 million in its third quarter.

The Redwood City, California-based company said it had a loss of 78 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.

The provider of oncology testing services posted revenue of $74.6 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $66.5 million.

Guardant Health shares have increased 50% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $117.46, a climb of 73% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about GUARDANT HEALTH, INC.
01/19GUARDANT HEALTH : to Partner With Vall d'Hebron Institute of Oncology to Set Up ..
MT
01/18GUARDANT HEALTH : and Vall d'Hebron Institute of Oncology Announce Partnership t..
BU
01/14GUARDANT HEALTH : to Present Data at ASCO Gastrointestinal Cancers Symposium Sho..
BU
01/11GUARDANT HEALTH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
01/11GUARDANT HEALTH : Stifel Starts Guardant Health at Buy With $175 Price Target
MT
01/07GUARDANT HEALTH, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
2020GUARDANT HEALTH : to Participate in the 39th Annual J.P. Morgan Healthcare Confe..
BU
2020GUARDANT HEALTH : AMEA Wins Frost & Sullivan's Market Leadership Award for Liqui..
AQ
2020Guardant Health Names Michael Bell as CFO
MT
2020GUARDANT HEALTH, INC. : Change in Directors or Principal Officers, Regulation FD..
AQ
More news
Financials (USD)
Sales 2020 285 M - -
Net income 2020 -218 M - -
Net cash 2020 1 305 M - -
P/E ratio 2020 -73,9x
Yield 2020 -
Capitalization 16 202 M 16 202 M -
EV / Sales 2020 52,3x
EV / Sales 2021 39,8x
Nbr of Employees 622
Free-Float 92,6%
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Average target price 151,82 $
Last Close Price 162,06 $
Spread / Highest target 17,2%
Spread / Average Target -6,32%
Spread / Lowest Target -48,8%
EPS Revisions
Managers and Directors
NameTitle
Helmy Eltoukhy Chief Executive Officer & Director
AmrAli H. Talasaz Chairman, President & Chief Operations Officer
Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors
1st jan.Capitalization (M$)
GUARDANT HEALTH, INC.25.74%16 202
EXACT SCIENCES CORPORATION11.76%23 548
BGI GENOMICS CO., LTD.38.46%10 188
INVITAE CORPORATION27.07%9 388
ADAPTIVE BIOTECHNOLOGIES CORPORATION13.33%9 165
IOVANCE BIOTHERAPEUTICS, INC.2.69%6 990